Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies

S Paul, E Candelario-Jalil - Experimental neurology, 2021 - Elsevier
Stroke is the leading cause of disability and thesecond leading cause of death worldwide.
With the global population aged 65 and over growing faster than all other age groups, the …

Role of endothelial dysfunction in atherosclerosis

J Davignon, P Ganz - Circulation, 2004 - Am Heart Assoc
As the major regulator of vascular homeostasis, the endothelium exerts a number of
vasoprotective effects, such as vasodilation, suppression of smooth muscle cell growth, and …

Adhesion molecules and atherosclerosis

S Blankenberg, S Barbaux, L Tiret - Atherosclerosis, 2003 - Elsevier
One early phase of atherosclerosis involves the recruitment of inflammatory cells from the
circulation and their transendothelial migration. This process is predominantly mediated by …

Beneficial cardiovascular pleiotropic effects of statins

J Davignon - Circulation, 2004 - Am Heart Assoc
Pleiotropic effects of a drug are actions other than those for which the agent was specifically
developed. These effects may be related or unrelated to the primary mechanism of action of …

Inflammation and infections as risk factors for ischemic stroke

PJ Lindsberg, AJ Grau - Stroke, 2003 - Am Heart Assoc
Background—Inflammatory processes have fundamental roles in stroke in both the etiology
of ischemic cerebrovascular disease and the pathophysiology of cerebral ischemia. We …

HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells

W Dichtl, J Dulak, M Frick, HF Alber… - … , and vascular biology, 2003 - Am Heart Assoc
Objective—Pleiotropic atheroprotective effects of HMG-CoA reductase inhibitors may be
mediated on the level of vascular gene transcription. The aim of this study was to …

The lipid and non-lipid effects of statins

AS Wierzbicki, R Poston, A Ferro - Pharmacology & therapeutics, 2003 - Elsevier
The 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase inhibitors, more
commonly known as statins, are a class of drug widely used for the treatment of …

Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease

AM Lefer, R Scalia, DJ Lefer - Cardiovascular research, 2001 - academic.oup.com
1. Introduction cholesterol lowering effect. Nevertheless, quite recently, the statins were
found to exert direct cardiovascular effects In 1976, Endo et al.[1] reported on the discovery …

Molecular targets of statins and their potential side effects: Not all the glitter is gold

KK Patel, VS Sehgal, K Kashfi - European journal of pharmacology, 2022 - Elsevier
Statins are a class of drugs widely used worldwide to manage hypercholesterolemia and the
prevention of secondary heart attacks. Currently, available statins vary in terms of their …

Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside

D Tousoulis, C Antoniades, N Koumallos… - Cytokine & growth factor …, 2006 - Elsevier
Cytokines are produced in a variety of tissues and regulate the expression of a number of
inflammatory molecules, leading to destabilization and finally rupture of vulnerable …